CHIBOGU OBIANWU: Open Payments
NPI 1710606298 · LAKE FOREST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,190 in 52 payments from 12 companies in 2025. Trend: 2023 $265 · 2024 $316 · 2025 $1,190
Food & beverage: $1,190
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 10 | $370 |
| ABBVIE INC. | 14 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Alkermes, Inc. | 4 | $78 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Neos Therapeutics, LP | 1 | $23 |
Products named: Dyanavel XR, VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, ARISTADA, Auvelity, LYBALVI.
Industry payments across IL — which companies pay providers there.
